
FirstString Research
FirstString Research | healing power.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
N/A | $26.7m | Series D | |
Total Funding | 000k |
Related Content
FirstString Research is a biopharmaceutical company specializing in the development of innovative therapies for wound healing and tissue regeneration. The company operates in the healthcare and biotechnology market, targeting patients with chronic wounds, surgical wounds, and other tissue repair needs. FirstString Research employs a business model focused on research and development, clinical trials, and partnerships with healthcare providers and pharmaceutical companies. Revenue is generated through the commercialization of its proprietary therapies, licensing agreements, and strategic collaborations. The company serves a diverse client base, including hospitals, clinics, and healthcare professionals, aiming to improve patient outcomes and quality of life.
Keywords: biopharmaceutical, wound healing, tissue regeneration, chronic wounds, surgical wounds, healthcare, biotechnology, clinical trials, proprietary therapies, strategic collaborations.